Jialin Hu Selected Research

Jialin Hu Research Topics

Disease

3	Neoplasms (Cancer) 02/2024 - 01/2021
3	Cognitive Dysfunction 02/2024 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2021
3	Wounds and Injuries (Trauma) 03/2023 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2021
2	Burns 03/2023 - 01/2022
2	Blast Crisis (Blast Phase) 01/2020 - 11/2018
1	Bites and Stings (Sting) 02/2024
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Neuroinflammatory Diseases 10/2023
1	Pain (Aches) 03/2023
1	Wound Infection (Wound Infections) 03/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Enteritis 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2022
1	Chronic Disease (Chronic Diseases) 06/2022
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Periodontitis 06/2022
1	Diabetes Complications 06/2022
1	Diabetes Mellitus 06/2022
1	COVID-19 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Corneal Injuries 01/2022
1	Cysts 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Leukemia 11/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2018
1	Fibrosis (Cirrhosis) 09/2018

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	Therapeutic UsesIBA 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 02/2024
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2024
1	Liposomes (Liposome)IBA 02/2024
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2024
1	Gefitinib (Iressa)FDA Link 11/2023
1	ErbB Receptors (EGF Receptor)IBA 11/2023
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 10/2023
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	ChitosanIBA 03/2023
1	CytokinesIBA 10/2022
1	AntioxidantsIBA 06/2022
1	mRNA VaccinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	AnisomycinIBA 11/2018
1	bcr-abl Fusion ProteinsIBA 11/2018
1	Dasatinib (BMS 354825)FDA Link 11/2018
1	p38 Mitogen-Activated Protein KinasesIBA 11/2018
1	CateninsIBA 11/2018
1	Imatinib Mesylate (Gleevec)FDA Link 11/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2018
1	Metalloproteases (Metalloproteinases)IBA 09/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2018
1	Fibronectins (Fibronectin)IBA 09/2018
1	Cadherins (E-Cadherin)IBA 09/2018
1	QuercetinIBA 09/2018
1	CollagenIBA 09/2018
1	TensinsIBA 09/2018
1	MicroRNAs (MicroRNA)IBA 09/2018

Therapy/Procedure

2	Therapeutics 02/2024 - 01/2020
1	Drug Therapy (Chemotherapy) 02/2024
1	Immunotherapy 02/2024
1	Oral Administration 11/2023
1	Debridement 01/2022
1	Skin Transplantation (Skin Grafting) 01/2022
1	Anesthesia 01/2022
1	Nephrectomy 01/2021